D.E. Shaw & Co’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.71M | Buy |
681,159
+139,879
| +26% | +$785K | ﹤0.01% | 2397 |
|
|
2025
Q4 | $3.79M | Buy |
541,280
+246,844
| +84% | +$1.93M | ﹤0.01% | 2544 |
|
|
2025
Q3 | $2.28M | Buy |
294,436
+153,224
| +109% | +$1.2M | ﹤0.01% | 2872 |
|
|
2025
Q2 | $1.23M | Sell |
141,212
-567,531
| -80% | -$4.11M | ﹤0.01% | 3090 |
|
|
2025
Q1 | $5.64M | Buy |
708,743
+501,746
| +242% | +$5.08M | 0.01% | 1803 |
|
|
2024
Q4 | $1.88M | Buy |
206,997
+152,926
| +283% | +$1.48M | ﹤0.01% | 2775 |
|
|
2024
Q3 | $496K | Sell |
54,071
-136,312
| -72% | -$1.13M | ﹤0.01% | 3706 |
|
|
2024
Q2 | $1.86M | Sell |
190,383
-386,104
| -67% | -$4.71M | ﹤0.01% | 2715 |
|
|
2024
Q1 | $8.7M | Buy |
576,487
+313,867
| +120% | +$5.7M | 0.01% | 1466 |
|
|
2023
Q4 | $5.66M | Buy |
262,620
+145,001
| +123% | +$2.68M | ﹤0.01% | 1806 |
|
|
2023
Q3 | $2.19M | Sell |
117,619
-622,413
| -84% | -$14.5M | ﹤0.01% | 2491 |
|
|
2023
Q2 | $18.7M | Sell |
740,032
-751,913
| -50% | -$18.9M | 0.02% | 909 |
|
|
2023
Q1 | $38.6M | Sell |
1,491,945
-1,081,897
| -42% | -$29M | 0.04% | 530 |
|
|
2022
Q4 | $60.9M | Sell |
2,573,842
-447,104
| -15% | -$12.1M | 0.07% | 355 |
|
|
2022
Q3 | $76.6M | Buy |
3,020,946
+948,465
| +46% | +$33.3M | 0.09% | 244 |
|
|
2022
Q2 | $68.8M | Buy |
2,072,481
+1,668,289
| +413% | +$70.9M | 0.08% | 283 |
|
|
2022
Q1 | $29.2M | Buy |
404,192
+207,165
| +105% | +$14.9M | 0.03% | 787 |
|
|
2021
Q4 | $18.1M | Sell |
197,027
-161,003
| -45% | -$19.2M | 0.02% | 1153 |
|
|
2021
Q3 | $45.4M | Buy |
358,030
+205,527
| +135% | +$29.9M | 0.04% | 577 |
|
|
2021
Q2 | $25.4M | Buy |
152,503
+32,501
| +27% | +$5.27M | 0.02% | 884 |
|
|
2021
Q1 | $21.8M | Buy |
120,002
+91,207
| +317% | +$21.2M | 0.02% | 879 |
|
|
2020
Q4 | $5.76M | Buy |
+28,795
| New | +$5.86M | 0.01% | 1765 |
|
|
2020
Q3 | – | Sell |
-88,111
| Closed | -$18.7M | – | 4155 |
|
|
2020
Q2 | $16.8M | Sell |
88,111
-353,068
| -80% | -$61.9M | 0.02% | 875 |
|
|
2020
Q1 | $68.4M | Buy |
+441,179
| New | +$51.3M | 0.11% | 218 |
|
|
2018
Q2 | – | Sell |
-9,896
| Closed | -$483K | – | 3888 |
|
|
2018
Q1 | $399K | Buy |
+9,896
| New | +$374K | ﹤0.01% | 2996 |
|
|
2017
Q3 | – | Sell |
-106,450
| Closed | -$3.69M | – | 3602 |
|
|
2017
Q2 | $3.69M | Sell |
106,450
-40,078
| -27% | -$1.17M | 0.01% | 1561 |
|
|
2017
Q1 | $3.66M | Buy |
+146,528
| New | +$3.05M | 0.01% | 1479 |
|
|
2016
Q2 | – | Sell |
-10,311
| Closed | -$99K | – | 3530 |
|
|
2016
Q1 | $99K | Buy |
+10,311
| New | +$146K | ﹤0.01% | 3283 |
|
Other funds holding TDOC
VPM
VCM
VC
D.E. Shaw & Co's TDOC Position: Q1 2026 in Review
D.E. Shaw & Co increased its Teladoc Health (TDOC) stake by 26% in Q1 2026, buying an estimated $785K and bringing the position to 681,159 shares worth $3.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2397.
D.E. Shaw & Co first reported a position in TDOC in Q1 2016 and has held it in 28 quarters since. The position peaked at $76.6M in Q3 2022. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- D.E. Shaw & Co held 681,159 shares of Teladoc Health worth $3.71M as of Q1 2026.
- D.E. Shaw & Co bought 139,879 Teladoc Health shares in Q1 2026, an estimated $785K.
- Teladoc Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2397 holding.
- D.E. Shaw & Co first reported a position in Teladoc Health in Q1 2016 and has held it in 28 quarters since.
- D.E. Shaw & Co's Teladoc Health position peaked at $76.6M in Q3 2022.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.